Johnson & Johnson Covid-19 Vaccine On Hold

Johnson & Johnson paused their late-stage COVID-19 vaccine trial due to an unexplained illness in a participant. Such pauses are common to assess potential side effects. The participant's condition is being evaluated by independent and internal safety boards. This is the second COVID-19 vaccine trial pause, following AstraZeneca's trial halt due to a neurological condition. The FDA is investigating. Meanwhile, a second wave of COVID-19 cases is expected in the US, with hospitals in the UK already experiencing a surge. Despite the pauses, other US vaccine candidates continue in late-stage trials.

What is a common reason for pausing clinical trials like the one conducted by Johnson & Johnson?

• To increase the number of participants

• Due to unexplained illnesses in participants

• To change the trial location

• To celebrate successful results

What is a serious adverse event in the context of clinical trials?

• A mild cough

• A minor headache

• A profound rash or swelling

• A slight fever

Which other company's vaccine trial was paused due to a serious neurological condition?

• Novavax

• AstraZeneca

• Pfizer

• Moderna

What is expected to contribute to a second wave of COVID-19 cases in the US?

• Increased outdoor activities

• Improved weather conditions

• More people staying indoors

• Widespread vaccination

What is the current situation in UK hospitals as mentioned in the transcript?

• They are closing down

• They are seeing a surge in cases

• They are unaffected by the pandemic

• They are reducing staff